Our activities are organized around various strategies connected to tissue repair and tissue engineering.

The UMR 977 was created by INSERM in January 2009 after positive evaluation of two teams (A+) by the AERES, the BmIT-1 team   “Active Biomaterials and Tissue Engineering” managed by Dr Nadia Benkirane-Jessel, and another team, BmIT-2.

In 2013, for the renewal of our unit, we have proposed a new project based on the BmIT-1 team  “Active Biomaterials and Tissue Engineering”. We have proposed also a new name “Osteoarticular and Dental Regenerative Nanomedicine”, which reflects our scientific development in the field of smart hybrid materials and regenerative nanomedicine.

They concern domains such as tooth engineering, bone repair, bone metastasis and cartilage regeneration.

In January 2018, V. Schini-Kerth, UMR CNRS 7213, Faculty of Pharmacy, University of Strasbourg, head of team “Experimental and Therapeutic Pharmacology” and L. Kessler (EA 7293) head of team “Vascular and tissular stress in transplantation” joined us for a promising project targeting vascular protection in health and diseases.

The UMR 1260 INSERM-UNISTRA, created in January 2018 under the direction of N. Benkirane-Jessel, is based on one team “Monoéquipe” entitled “Regenerative Nanomedicine”. Our UMR 1260 is based on 2 themes: “Osteoarticular and Dental Regenerative Nanomedicine” theme, headed by N. Benkirane-Jessel and “Therapeutic Pharmacology and Vascular Regeneration” theme, headed by V. Schini-Kerth. These two themes will work together and focus on the 3 programs validated by the INSERM and our University  » Université de Strasbourg ».

Our Unit affiliation (UMR 1260) is INSERM and University of Strasbourg.

Companies, you can support our laboratory thanks to the apprenticeship tax

We are an Inserm research unit located in the Faculty of Medicine of Strasbourg, which brings together researchers and teachers working in the field of tissue repair, tissue engineering and drug delivery. As part of the curriculum offered by the faculty, we train students in these areas.

We finance this training from university endowments and grants paid as part of the apprenticeship tax. The contribution of companies is essential to our activity, in an increasingly constrained public framework to allow us to continue to train these young physicians in good conditions, and who will be available on the market tomorrow to collaborate on your projects.

By paying us your apprenticeship tax, you are providing valuable support to our unit and also contributing to the future performance of your business. The apprenticeship tax is used to finance the purchase of materials for the organization of the Practical and Supervised Work of these lessons.

This is why we would be grateful if you could retain our laboratory for the payment of a grant opening the right to exemption from apprenticeship tax. The very diversified training that we provide allows us to receive this tax under the categories « senior executives » and « middle and senior executives combined ».

You will find, here the form in PDF format to download and send to your financial department.

With our thanks!


Dr. Nadia Benkirane-Jessel, PhD, HDR

Research Director, DR1 Inserm
Regenerative NanoMedicine Unit Director
French National Institute of Health and Medical Research (INSERM)

UMR 1260, INSERM / Université de Strasbourg
CRBS, Centre de recherche en Biomédecine de Strasbourg
1 Rue Eugene Boeckel Étage 2 

Phone : (33)-3-68-85-33-76
Fax : (33)-3-68-85-33-01
Email : nadia.jessel@inserm.fr